News
Novo Nordisk now has an Ozempic pill. Citing a Novo spokesperson, pharmaceuticals news site BioPharmaDive reported yesterday ...
Awarded annually, the Breakthrough Prize, often referred to as the “Oscars of Science,” seeks to “celebrate the wonders of ...
From cayenne pepper to berberine, here are four essential herbs that are great for weight loss and metabolism support.
Almost unarguably, the most significant story in our time with the pharmaceutical industry is the emergence and sharp rise of GLP-1 obesity drugs. Front and center of this is Novo Nordisk (NYSE: NVO), ...
Following competitor Novartis, pharma giant Roche also announces massive investments in the United States. Swiss jobs and ...
Novo Nordisk, maker of Ozempic, applied for FDA approval for a weight loss pill, less than a week after rival Eli Lilly's clinical trial success.
During oral arguments, the defendants contended that the plaintiffs could not support their allegations that Novo Nordisk and ...
Nourished, the trusted leader in high-quality nutritional gummies, is excited to announce its expansion with the UK’s largest ...
Plus, salon owners are seeing a massive drawdown in clients coming in for their regular scheduled appointments, citing ...
Topline data were announced from a phase 3 trial evaluating orforglipron in adults with T2D and inadequate glycemic control with diet and exercise alone.
Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...
Novo Nordisk filed for approval of an oral, 25-mg formulation of semaglutide “earlier this year,” according to a company spokesperson.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results